About this trial
Gene therapy is a promising strategy to treat hearing loss and vestibular disorders, and Associated adenovirus (AAV) is shown as a good viral vector for inner ear therapy in animal models.
This study aims to study in vitro viral transduction of AAV in human inner ear cells, collected during non-conservative surgeries for vestibular schwannoma.
Eligibility criteria
Qualifiers
Patient ≥ 18 years old
Operative indication for a non-conservative resection of vestibular schwannoma, decided by the surgeon in accordance with the patient
Informed consent obtained
Patients with a french social protection (AME excluded)
Disqualifiers
Intravestibular or intra-cochlear extension of the tumor
Pregnant woman
Patient with administrative control
Medical contra-indication
Trial design
Treatments tested in this trial
- Peroperative collect of inner ear cells
Treatment groups
Sponsors and collaborators
Institut Pasteur
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Collaborator